share_log

多款明星产品闪耀登场,复锐医疗科技连续七年亮相进博会

Many star products shine on stage, sisram med has appeared at the Import Expo for seven consecutive years.

PR Newswire ·  Nov 11 11:56

Hong Kong, November 11, 2024 /PRNewswire/ -- The 7th China International Import Expo was held in Shanghai from November 5 to 10. Taking this opportunity, Furui Medical Technology Co., Ltd. (hereinafter referred to as the “Company” or “Furui Medical Technology”; English “Sisram Medical”; stock code: 1696.HK), as a global beautiful health group, continues to participate in the exhibition this year. The company's booth is located at 7.1B03 in the Medical Devices and Healthcare Zone, marking the 7th year in a row for the company to participate in the exhibition expo. Over the years, Fu Rui Medical Technology has been committed to continuous innovation, continuously enriching its beauty and health product portfolio, providing beauty seekers with more diverse beauty choices and excellent clinical treatment experiences, with the aim of achieving the long-term mission of “improving the quality of life and embarking on an excellent journey”.

Bringing together the essence of medical aesthetics and cutting-edge technology in the industry, FuRui Medical Technology showcased a variety of classic product portfolios at the conference, including: two innovative and classic energy source medical and aesthetic equipment products under Alma, the world's leading provider of energy source medical and aesthetic equipment — Gently Lifting Young and Opus superionic devices; PROFHILO, a high-concentration hyaluronic acid product without chemical crosslinkers; the world's first long-acting type A botulinum toxin product, Dasifil; and home medical grade beauty care equipment created with love for consumers LMNT One+ and LMNT O₂.

The flagship product is classic anti-aging, and the core energy source constructs three-dimensional support

At this fair, FuRui Medical Technology showcased two energy source devices, the Light-Lift Young and Opus Super Ion Devices, which attracted much attention. Lifting Young is the latest generation of light anti-aging equipment using 40.68 MHz radio frequency technology. It can effectively improve problems such as sagging skin, fat accumulation, and sagging tissue without narcotics and pain, and there is no recovery period after treatment. Opus superion devices use radio frequency and unique plasma technology to stimulate collagen regeneration and remodeling through dual thermal energy. At the same time, it also optimizes the novel energy source superions to achieve non-gaseous exfoliation and non-pigmentation, shorten the repair period and have no risk of depigmentation, solve various texture and skin quality problems, and achieve lightening, tightening, and uniform color in one step. As a global leader in energy source medical and aesthetic equipment, Alma is committed to providing patients with the most effective, fast and safe treatment solutions using the most advanced medical aesthetic technology, and continues to build a solid foundation for FuRui Medical Technology to consolidate the company's global market leadership position.

Bioremediation is attracting attention, and injection-filling pipelines are ready to go

As an industry-leading platform for beauty and health, FuRui Medical Technology continues to work to build and improve its beautiful health ecosystem and continuously strengthen the company's core competitiveness. The company's injection filling business also achieved remarkable results this year, creating a core second growth curve and continuous input momentum for the company. PROFHILO, the injectable filler product presented this time is one of the highest concentration of hyaluronic acid products in the world. The product was approved by the Hainan Drug Administration in June of this year and landed in Hainan as a licensed pharmaceutical device, which is expected to better meet the new needs of beauty seekers for innovative international pharmaceutical devices. As a 100% pure hyaluronic acid product without crosslinkers, PROFHILO has both hydrating and brightening effects and excellent lifting ability, which can effectively improve skin quality and combat skin sagging. Through the combined effects of macromolecular hyaluronic acid and small-molecule hyaluronic acid in its ingredients, PROFHILO can support the dermis while stimulating the regeneration of collagen and elastin in the dermal layer, thereby effectively smoothing skin wrinkles and fine lines, and achieving multi-level skin rejuvenation. More importantly, PROFHILO can achieve ultimate treatment results even with reduced injection doses and shorter treatment times.


Figure 3: PROFHILO biological remodeling therapy

Furthermore, the registration application for the long-acting type A botulinum toxin product Dashiffe, which is highly anticipated by the market, was officially approved by the China National Drug Administration in September this year, and it is expected to be officially launched in China next year. As the world's first long-acting type A botulinum toxin product and the sixth botulinum toxin product approved in China, Dashibi uses patented peptide exchange technology (PXT) combined with botulinum toxin, which can quickly improve lines between eyebrows and gradually recover over a long period of time, providing excellent curative effects for beauty seekers. In addition to excellent clinical treatment results, since its excipients do not contain human blood protein or animal-derived ingredients, the probability of allergic and immune reactions during treatment is lower, which can meet the safety requirements of beauty seekers. Additionally, due to its flexibility in storage, Dashibi can also provide physicians with more convenient and controlled storage management.

A rich product portfolio empowers the future, and cutting-edge technology “recharges” the skin

Adhering to the customer-centered development concept, FuRui Medical Technology relies on many years of technical advantages to create the LMNT series of personal care products, aiming to provide consumers with a more convenient and professional home medical-grade beauty care experience. The LMNT brand is engraved with the seal of the company's medical-grade beauty and health solutions, representing the company's many years of expertise and commitment to the highest quality. It incorporates energy-based home beauty device products into daily skin care and care to restore radiance and vitality to consumers.

The LMNT One+ and LMNT O₂ showcased at this fair are also handheld beauty devices. Both are equipped with micropulse technology. LMNT One+ uses LED photonic technology - a combination of 633±15nm red light and 830 nm 15nm NIR infrared light to help promote skin collagen regeneration and long-lasting anti-aging. On this basis, LMNT O₂ also uses 415 ± 15 nm of blue light to solve skin problems with acne, and has excellent treatment effects on skin problems such as acne, cleft mouth, and oily skin.

As the world's first import-themed national exhibition, the China International Import Expo is a major initiative by China to open up its market to the world. As of October 2024, the CIIE has organized more than 1,130 foreign-funded enterprises and investment promotion agencies to go to various regions to carry out accurate matchmaking, becoming an international platform for global sharing. As the world's leading beauty and health group, FuRui Medical Technology always adheres to the customer-centered development concept, strives to create a more differentiated and comprehensive product and service portfolio, and continues to provide customers with professional and diverse comprehensive beauty and health solutions.

About FuRui Medical Technology

Fu Rui Medical Technology Co., Ltd. (stock code: 1696.HK) is a global beauty health group. Its unique beauty and health ecosystem provides a diversified product portfolio to create a customer-centered brand. Its business includes energy source medical and aesthetic equipment, injection filling, cosmetic and digital dentistry, personal care, etc. FuRui Medical Technology is a holding subsidiary of Fosun Pharmaceuticals, a leading healthcare industry group in China. It was listed in Hong Kong, China in September 2017.

FuRui Medical Technology - Improving Quality of Life

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment